Projects per year
Personal profile
Education
- 1994.09-2002.08 Ph.D., Graduate Institute of Life Science, National Defense Medical Center
- 1991-1993 M.S., Department of Aquaculture, National Taiwan Ocean University
- 1984-1988 B.S., Department of Aquaculture, National Taiwan Ocean University
Experience
- 2024.07- Professor, Department of Physiology, School of Medicine, Taipei Medical University
- 2017.08- Professor, Master Program fro Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2014.08- Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 2024.03-2024.06 Professor, Institute of Pharmacognosy, School of Pharmacy, Taipei Medical University
- 2024.03-2024.06 Professor, Department of Physiology（Joint Appointment）, School of Medicine, Taipei Medical University
- 2014.08-2024.03 Professor, Department of Physiology, School of Medicine, Taipei Medical University
- 2018.03-2024.03 Director, Department of Physiology, School of Medicine, College of Medicine, Taipei Medical University
- 2016.08-2019.01 Director, Ph.D. Program in Biotechnology Research and Development, Taipei Medical University
- 2011.08-2014.07 Associated Professor, Department of Physiology, School of Medicine, Taipei Medical UniversityDepartment of Physiology
- 2010.02-2011.07 Associated professor, Master Program/Ph.D. Program in Pharmacology and Toxicology, Tzu Chi University
- 2006.02-2010.02 Assistant professor, Master Program/Ph.D. Program in Pharmacology and Toxicology, Tzu Chi University
- 2005.08-2006.02 Postdoctoral Researcher, Academia Sinica
- 2004.02-2005.07 Assistant professor, Department of Internal Medicine, School of Medicine, Taipei Medical University
- 2003.08-2004.02 Postdoctoral Researcher, Institute of Biomedical Sciences, Academic Sinica
- 2002.08-2003.07 Manger, Department of Research and Development
Related Link
Research Interests
- Renolpathology
- molecular biology
- Renal pathophysiology animal model
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 14 Life Below Water
Fingerprint
Dive into the research topics where Heng Lin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 18 Finished
-
探討誘發多/超多倍體導致慢性腎臟病之生理意義機轉及可能之臨床應用
Lin, H. (PI)
8/1/25 → 7/31/26
Project: B - Project of TMU › i - Other (Funded by TMU)
-
探討微小RNA-494在「5/6 腎臟切除合併 左腎入腎動脈上分支打結手術」模式下 造成的慢性腎臟病中所扮演的角色
Lin, H. (PI)
7/1/24 → 2/28/25
Project: A - Government Institution › b - National Science and Technology Council
-
Targeting the Adipokines/Batokines Secreted from Afferent Renal Artery Adipocyte Tissue to Explore the Obesity Induced Diabetic Renal Pathophysiology Role under Atf3 Regulation and the Basic and Clinical Therapeutic Application.
Lin, H. (PI)
8/1/22 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
Development of a new drug as a translational medical study to improve the obesity and obesity-induced diabetes nephropathy syndrome
Lin, H. (PI)
8/1/21 → 7/31/22
Project: A - Government Institution › b - National Science and Technology Council
-
Development of a New Drug as a Translational Medical Study to Improve the Obesity and Obesity-Induced Diabetes Nephropathy Syndrome
Lin, H. (PI)
8/1/20 → 7/1/21
Project: A - Government Institution › b - National Science and Technology Council
-
Activating transcription factor-3 orchestrates the modulation of vascular anti-contractile activity and relaxation by governing the secretion of HDL-bound sphingosine-1-phosphate in perivascular adipose tissue
Li, H. F., Lin, H., Liu, H. T., Lin, T. J. & Tseng, T. L., 2025, In: British Journal of Pharmacology. 182, 8, p. 1763-1782 20 p.Research output: Contribution to journal › Article › peer-review
3 Link opens in a new tab Citations (Scopus) -
ST32da, a Novel Salvia miltiorrhiza-Derived ATF3 Inducer, Alleviates Obesity-Related Diabetic Nephropathy in Mouse Models
Chen, H. H., Tseng, T. L., Li, H. F., Hsieh, Y. T., Tran, T. T., Wu, Y. L. & Lin, H., Dec 2025, In: Cells. 14, 23, 1893.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
Exploration and biological evaluation of 7-methoxy-3-methyl-1H-chromeno[4,3-c]pyrazol-4-one as an activating transcription factor 3 inducer for managing metabolic syndrome
Chang, Y. H., Lin, H., Li, H. F., Chen, H. H. & Hung, H. Y., Jan 15 2023, In: European Journal of Medicinal Chemistry. 246, 114951.Research output: Contribution to journal › Article › peer-review
7 Link opens in a new tab Citations (Scopus) -
New Synthesized Activating Transcription Factor 3 Inducer SW20.1 Suppresses Resistin-Induced Metabolic Syndrome
Tran, T. T., Huang, W. J., Lin, H. & Chen, H. H., Jun 2023, In: Biomedicines. 11, 6, 1509.Research output: Contribution to journal › Article › peer-review
Open Access4 Link opens in a new tab Citations (Scopus) -
Perivascular adipose tissue and adipocyte-derived exosomal miRNAs maintain vascular homeostasis
Chen, H. H., Li, H. F., Tseng, T. L. & Lin, H., Dec 2023, In: Heliyon. 9, 12, e22607.Research output: Contribution to journal › Review article › peer-review
Open Access10 Link opens in a new tab Citations (Scopus)